Invention Grant
- Patent Title: Compounds which selectively modulate the CB2 receptor
- Patent Title (中): 选择性调节CB2受体的化合物
-
Application No.: US12564132Application Date: 2009-09-22
-
Publication No.: US08048899B2Publication Date: 2011-11-01
- Inventor: Alessandra Bartolozzi , Angela Berry , Eugene Richard Hickey , Markus Ostermeier , Doris Riether , Achim Sauer , David Smith Thomson , Lifen Wu , Renee M. Zindell , Patricia Amouzegh , Nigel James Blumire , Stephen Peter East , Monika Ermann , Someina Khor , Innocent Mushi
- Applicant: Alessandra Bartolozzi , Angela Berry , Eugene Richard Hickey , Markus Ostermeier , Doris Riether , Achim Sauer , David Smith Thomson , Lifen Wu , Renee M. Zindell , Patricia Amouzegh , Nigel James Blumire , Stephen Peter East , Monika Ermann , Someina Khor , Innocent Mushi
- Applicant Address: DE Ingelheim am Rhein
- Assignee: Boehringer Ingelheim International GmbH
- Current Assignee: Boehringer Ingelheim International GmbH
- Current Assignee Address: DE Ingelheim am Rhein
- Agent Michael P. Morris; Anthony P. Bottino
- Main IPC: A61K31/433
- IPC: A61K31/433 ; A61K31/42 ; A61K31/422 ; A61K31/4196 ; C07D285/135 ; C07D413/12 ; C07D261/14 ; C07D249/16
Abstract:
are disclosed. Compounds according to the invention bind to and are agonists, antagonists or inverse agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.
Public/Granted literature
- US20100081644A1 Compounds Which Selectively Modulate The CB2 Receptor Public/Granted day:2010-04-01
Information query
